최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of microbiology and biotechnology, v.31 no.1, 2021년, pp.25 - 32
Krishnan, Manigandan (Department of Bioscience and Biotechnology, Konkuk University) , Choi, Joonhyeok (Department of Bioscience and Biotechnology, Konkuk University) , Choi, Sungjae (Department of Bioscience and Biotechnology, Konkuk University) , Kim, Yangmee (Department of Bioscience and Biotechnology, Konkuk University)
Inflammatory reactions activated by lipopolysaccharide (LPS) of gram-negative bacteria can lead to severe septic shock. With the recent emergence of multidrug-resistant gram-negative bacteria and a lack of efficient ways to treat resulting infections, there is a need to develop novel anti-endotoxin ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
1 Drayton M Kizhakkedathu JN Straus SK 2020 Towards robust delivery of antimicrobial peptides to combat bacterial resistance Molecules 25 3048 10.3390/molecules25133048 32635310
2 Hollmann A Martinez M Maturana P Semorile LC Maffia PC 2018 Antimicrobial peptides: Interaction with model and biological membranes and synergism with chemical antibiotics Front. Chem. 6 204 10.3389/fchem.2018.00204 29922648
3 Torres MDT Sothiselvam S Lu TK de la Fuente-Nunez C 2019 Peptide design principles for antimicrobial applications J. Mol. Biol. 431 3547 3567 10.1016/j.jmb.2018.12.015 30611750
4 Breijyeh Z Jubeh B Karaman R 2020 Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it Molecules 25 1340 10.3390/molecules25061340 32187986
5 Polat G Ugan RA Cadirci E Halici Z 2017 Sepsis and septic shock: Current treatment strategies and new approaches Eur. J. Med. 49 53 58 10.5152/eurasianjmed.2017.17062 28416934
6 Park BS Lee JO 2013 Recognition of lipopolysaccharide pattern by TLR4 complexes Exp. Mol. Med. 45 e66 10.1038/emm.2013.97 24310172
7 Ramachandran G 2014 Gram-positive and gram-negative bacterial toxins in sepsis: a brief review Virulence 5 213 218 10.4161/viru.27024 24193365
8 Nathan C 2002 Points of control in inflammation Nature 420 846 852 10.1038/nature01320 12490957
9 Gabay C 2006 Interleukin-6 and chronic inflammation Arthritis Res. Ther. 8 Suppl 2 S3 10.1186/ar1917 16899107
10 Williams KJ 2009 The introduction of 'chemotherapy' using arsphenamine - the first magic bullet J. R. Soc. Med. 102 343 348 10.1258/jrsm.2009.09k036 19679737
12 Lin L Wagner MC Cocklin R Kuzma A Harrington M Molitoris BA 2011 The antibiotic gentamicin inhibits specific protein trafficking functions of the Arf1/2 family of GTPases Antimicrob. Agents Chemother. 55 246 254 10.1128/AAC.00450-10 20956596
13 Codjoe FS Donkor ES 2017 Carbapenem resistance: a review Med. Sci. (Basel) 6 1 10.3390/medsci6010001 29267233
14 Moellering RC Jr Wennersten C Kunz ESLJ 1976 Emergence of gentamicin-resistant bacteria: experience with tobramycin therapy of infections due to gentamicin-resistant organisms J. Infect. Dis. 134 Suppl S40 49 10.1093/infdis/134.Supplement_1.S40 972284
15 Hancock RE Chapple DS 1999 Peptide antibiotics Antimicrob. Agents Chemother. 43 1317 1323 10.1128/AAC.43.6.1317 10348745
16 Falagas ME Grammatikos AP Michalopoulos A 2008 Potential of old-generation antibiotics to address current need for new antibiotics Expert. Rev. Anti. Infect. Ther. 6 593 600 10.1586/14787210.6.5.593 18847400
17 Martin L van Meegern A Doemming S Schuerholz T 2015 Antimicrobial peptides in human sepsis Front. Immunol. 6 404 10.3389/fimmu.2015.00404 26347737
18 Shin S Kim JK Lee JY Jung KW Hwang JS Lee J 2009 Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action J. Pept. Sci. 15 559 568 10.1002/psc.1156 19598182
19 Krishnan M Choi J Jang A Kim Y 2020 A Novel Peptide Antibiotic, Pro10-1D, Designed from insect defensin shows antibacterial and anti-inflammatory activities in sepsis models Int. J. Mol. Sci. 21 6216 10.3390/ijms21176216 32867384
20 Lee E Kim JK Shin S Jeong KW Lee J Lee DG 2011 Enantiomeric 9-mer peptide analogs of protaetiamycine with bacterial cell selectivities and anti-inflammatory activities J. Pept. Sci. 17 675 682 10.1002/psc.1387 21766387
21 Kim J Jacob B Jang M Kwak C Lee Y Son K 2019 Development of a novel short 12-meric papiliocin-derived peptide that is effective against Gram-negative sepsis Sci. Rep. 9 3817 10.1038/s41598-019-40577-8 30846839
22 Lee E Kim JK Jeon D Jeong KW Shin A Kim Y 2015 Functional roles of aromatic residues and helices of papiliocin in its antimicrobial and anti-inflammatory activities Sci. Rep. 5 12048 10.1038/srep12048 26156126
23 Jeon D Jeong MC Jacob B Bang JK Kim EH Cheong C 2017 Investigation of cationicity and structure of pseudin-2 analogues for enhanced bacterial selectivity and anti-inflammatory activity Sci. Rep. 7 1455 10.1038/s41598-017-01474-0 28469145
24 Wood SJ Miller KA David SA 2004 Anti-endotoxin agents. 1. Development of a fluorescent probe displacement method optimized for the rapid identification of lipopolysaccharide-binding agents Comb. Chem. High Throughput. Screen. 7 239 249 10.2174/1386207043328832 15134530
25 Jang M Kim J Choi Y Bang J Kim Y 2019 Antiseptic effect of Ps-K18: mechanism of its antibacterial and anti-inflammatory activities Int. J. Mol. Sci. 20 4895 10.3390/ijms20194895 31581682
29 van der Does AM Beekhuizen H Ravensbergen B Vos T Ottenhoff TH van Dissel JT 2010 LL-37 directs macrophage differentiation toward macrophages with a proinflammatory signature J. Immunol. 185 1442 1449 10.4049/jimmunol.1000376 20610648
30 Wang J Gong S Wang F Niu M Wei G He Z 2019 Granisetron protects polymicrobial sepsis-induced acute lung injury in mice Biochem. Biophys. Res. Commun. 508 1004 1010 10.1016/j.bbrc.2018.12.031 30551881
31 Ventola CL 2015 The antibiotic resistance crisis: part 1: causes and threats P T. 40 277 283 25859123
32 Mahlapuu M Hakansson J Ringstad L Bjorn C 2016 Antimicrobial peptides: An emerging category of therapeutic agents Front. Cell Infect. Microbiol. 6 194 10.3389/fcimb.2016.00194 28083516
33 Diamond G Beckloff N Weinberg A Kisich KO 2009 The roles of antimicrobial peptides in innate host defense Curr. Pharm. Des. 15 2377 2392 10.2174/138161209788682325 19601838
34 van der Does AM Bogaards SJ Ravensbergen B Beekhuizen H van Dissel JT Nibbering PH 2010 Antimicrobial peptide hLF1-11 directs granulocyte-macrophage colony-stimulating factor-driven monocyte differentiation toward macrophages with enhanced recognition and clearance of pathogens Antimicrob. Agents Chemother. 54 811 816 10.1128/AAC.00652-09 19933796
35 Vaara M 2009 New approaches in peptide antibiotics Curr. Opin. Pharmacol. 9 571 576 10.1016/j.coph.2009.08.002 19734091
36 Lin GY Chang CF Lan CY 2020 The interaction between carbohydrates and the antimicrobial peptide P-113Tri is involved in the killing of Candida albicans Microorganisms 8 299 10.3390/microorganisms8020299 32098211
37 Scott A Weldon S Buchanan PJ Schock B Ernst RK McAuley DF 2011 Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo PLoS One 6 e26525 10.1371/journal.pone.0026525 22028895
38 Monteiro C Pinheiro M Fernandes M Maia S Seabra CL Ferreira-da-Silva F 2015 A 17-mer membrane-active MSI-78 derivative with improved selectivity toward bacterial cells Mol. Pharm. 12 2904 2911 10.1021/acs.molpharmaceut.5b00113 26066462
39 Lin Z Zhao X Huang J Liu W Zheng Y Yang X 2019 Rapid screening of colistin-resistant Escherichia coli , acinetobacter baumannii and Pseudomonas aeruginosa by the use of raman spectroscopy and hierarchical cluster analysis Analyst 144 2803 2810 10.1039/C8AN02220H 30882113
40 Kumar CG Sujitha P 2014 Kocuran, an exopolysaccharide isolated from Kocuria rosea strain BS-1 and evaluation of its in vitro immunosuppression activities Enzyme Microb. Technol. 55 113 120 10.1016/j.enzmictec.2013.10.007 24411453
41 Kumar P Kizhakkedathu JN Straus SK 2018 Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility In Vivo Biomolecules 8 4 10.3390/biom8010004 29351202
42 Morici P Florio W Rizzato C Ghelardi E Tavanti A Rossolini GM 2017 Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains Eur. J. Clin. Microbiol. Infect. Dis. 36 1739 1748 10.1007/s10096-017-2987-7 28470337
43 Ong ZY Cheng J Huang Y Xu K Ji Z Fan W 2014 Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic beta-sheet forming peptide amphiphiles Biomaterials 35 1315 1325 10.1016/j.biomaterials.2013.10.053 24211081
44 Ding L Yang L Weiss TM Waring AJ Lehrer RI Huang HW 2003 Interaction of antimicrobial peptides with lipopolysaccharides Biochemistry 42 12251 12259 10.1021/bi035130+ 14567687
45 Lu YC Yeh WC Ohashi PS 2008 LPS/TLR4 signal transduction pathway Cytokine 42 145 151 10.1016/j.cyto.2008.01.006 18304834
46 Nolan JP Ali MV 1972 Effect of cholestyramine on endotoxin toxicity and absorption Am. J. Dig. Dis. 17 161 166 10.1007/BF02232738 4552124
47 Umeda M Niwa M Yamagami S Kishimot T Maekawa M Sawada Y 1990 Novel endotoxin adsorbing materials, polymyxinsepharose and polyporous polyethylene membrane for removal of endotoxin from dialysis systems Biomater. Artif. Cells Artif. Organs 18 491 497 10.3109/10731199009119623 2285811
49 Payen DM Guilhot J Launey Y Lukaszewicz AC Kaaki M Veber B 2015 Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial Intensive Care Med. 41 975 984 10.1007/s00134-015-3751-z 25862039
※ AI-Helper는 부적절한 답변을 할 수 있습니다.